Trial Details

COMPLETED
Basic Information
Clinical ID c1095
Identifier NCT01257386
Trial Title Comparative Efficacy and Safety Study in Patients With Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Active Ulcerative Colitis
Interventions DRUG: Asacol|DRUG: Mesalazine
Participant Information
Sponsor Tillotts Pharma AG
City Shanghai
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2025-11-10
Primary Completion Date 2025-08-12
Completion Date 2025-03-13